References

• • Dalal, K. (2011) Does economic empowerment protects women from intimate partner viole...
• • Dalal, K. and Lindqvist, K. (2010) A National study of the prevalence and correlates ...
• • Wagstaff, A. and van Doorslaer, E. (2003) Watanabe N. on decomposing the causes of he...
• • O’Donnell, O., van Doorslaer, E., Wagstaff, A. and Lindelow, M. (2008) Analysing heal...
• • Iqbal, J.M. (2007) In defence of Marxism, Bangladesh and the crisis over the caretake...
• • Ikeako, L.C., Onah, H.E. and Iloabachie, G.C. (2006) Influence of formal maternal edu...
• • Mekonnen, Y. and Mekonnen, A. (2003) Factors influencing the use of maternal health c...
• • UNICEF (2010) Bangladesh: Statistics. Education. http://www.unicef.org/infobycountr...
• • Bangladesh Bureau of Educational Information and Statistics (2006). http://www.banb...
• • Nahar, S. and Costello, A. (1998) The hidden cost of “free” maternity care in Dhaka, ...
• • Killingsworth, J.R., Hossain, N., Hedrick-Wong, Y., Thomas, S.D., Rahman, A. and Begu...
• • Pathak, P.K., Singh, A. and Subramanian, S.V. 2010) Economic inequalities in maternal...
• • Chakraborty, N., Islam, M.A., Chowdhury, R.I., Bari, W. and Akhter, H.H. (2003) Deter...
• • Anwar, I., Kalim, N. and Koblinsky, M. (2009) Quality of obstetric care in public-sec...
• • European Parliament and Council Directive 2001/20/EC of 4 April 2001. OJ No L121/34 o...
• • German Drug Law (2004) 12 Gesetz zur Anderung des Arzneimittelgesetzes. Bundesgesetzb...
• • Wingen, F.I. and Beinhauer, K.G. (2002) Development of clinical drug trial and the fo...
• • Thompson, D.F. (1993) Understanding financial conflicts of interest. The New England ...
• • Weber, L.J. (2006) Profits before people? Ethical standards and the marketing of pres...
• • Montori, V.M., Smieja, M. and Guyatt, G.H. (2000) Publication bias: A brief review fo...
• • Hirsch, L. (2004) Randomized clinical trials: What gets published, and when? Canadian...
• • Department of Health and Human Services (2004) Financial relationships and interests ...
• • De Angelis, C., Drazen, J.M., Frizelle, F.A., Haug, C., Hoey, J., Horton, R., Kotzin,...
• • Davidoff, F., DeAngelis, C.D., Drazen, J.M., Nicholis, M.G., Hoey, J., Hojgaard, L., ...
• • FDA (2006) Guidance for clinical trial sponsors on the establishment and operation of...
• • Ahmer, S., Haider, I.J., Anderson, D. and Arya, P. (2006) Do pharmaceutical companies...
• • House of Commons Health Committee (2005) The influence of the pharmaceutical industry...
• • Ferner, R. (2005) The influence of big pharma. BMJ, 330, 855-856. doi:10.1136/bmj.330...
• • Turner, E.H., Matthews, A.M., Linardatos, E., Tell, R.A. and Rosenthal, R. (2008) Sel...
• • Melander, H., Ahlqvist-Rastad, J., Meijer, G. and Beermann, B. (2003) Evidence based ...
• • Lee, K., Bachetti, P. and Sim, I. (2008) Publication of clinical trials supporting su...
• • Rising, K., Bachetti, P. and Bero, L. (2008) Reporting bias in drug trials submitted ...
• • Schott, G., Pachl, H., Limbach, U., Gundert-Remy, U., Ludwig, W.D. and Lieb, K. (2010...
• • Schott, G., Pachl, H., Limbach, U., Gundert-Remy, U., Ludwig, W.D. and Lieb, K. (2010...
• • Kaiser, J. (2008) Making clinical data widely available. Science, 322, 217-218. doi:...
• • PloS Medicine Editors (2008) Next stop, don’t block the doors: Opening up access to c...
• • US Department of Health and Human Services (2007) Food and Drug Administration Amendm...
• • Hirsch, L. (2008) Trial registration and results disclosure: Impact of US legislation...
• • Mayor, S. (2005) Drug companies agree to make clinical trial results public. BMJ, 330...
• • PhRMA (2009) Revised clinical trial principles reinforce PhRMA’s commitment to transp...